ArtuVet Animal Health

ArtuVet Animal Health Overview

Status Acquired/​Merged
Latest Deal Type Buyout/​LBO
Financing Rounds 1

ArtuVet Animal Health General Information

Description

Developer and manufacturer of allergen-specific immunotherapy and pharmaceuticals. The company's allergen-specific immunotherapy and pharmaceuticals, prepared through a wealth of experience and knowledge in the field of diagnostics and the treatment of allergies, helps in the treatment of allergies in dogs by carefully studying the underlying causes and symptoms. It also focuses on a long-term effect and prevention.

Contact Information

Website
Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Private Equity-Backed
Primary Industry
Other Consumer Non-Durables
Other Industries
Other Services (B2C Non-Financial)
Parent Company
Primary Office
  • Vijzelweg 11
  • 8243 PM Lelystad
  • Netherlands
+31 0320 000 000
Want detailed data on 2M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

ArtuVet Animal Health Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore ArtuVet Animal Health‘s full profile, request access.

Request a free trial

ArtuVet Animal Health Executive Team (1)

Name Title Board Seat Contact Info
Bram Schuit Chief Executive Officer

ArtuVet Animal Health Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore ArtuVet Animal Health‘s full profile, request access.

Request a free trial